Admission Date:  [**2199-9-10**]              Discharge Date:   [**2199-9-17**]  Date of Birth:  [**2160-5-7**]             Sex:   F  Service: MEDICINE  Allergies: Ampicillin / Penicillins / Morphine Hcl  Attending:[**First Name3 (LF) 3918**] Chief Complaint: Chemotherapy  Major Surgical or Invasive Procedure: Chemotherapy Dialysis   History of Present Illness: 39-year-old woman with h/o type I diabetes since age 14 months, glomerulonephritis, kidney transplants in [**2174**] and [**2177**], and a double kidney and pancreas transplant on [**2188-11-20**], who has newly  diagnosed EBV-driven CNS lymphoma.
She was discharged on [**2199-8-30**] following an identical course of MTX and leucovorin- this admission required both HD and CVVH to manage toxicity in the setting of her renal transplant.
Since discharge, the patient had a negative ROS and no issues.
Past Medical History: PAST ONCOLOGIC HISTORY: ====================== Her neurological problems began in [**2199-3-22**] when her mother noted psychomotor slowing, short-term memory problems, inability to tolerate stress, and tremors in the hands.
By [**2199-4-22**], she had additional symptoms including word-finding difficulty and slurred speech.
She also had a workup for her mental status status change.
A head MRI without gadolinium performed on [**2199-5-31**]  showed moderate atrophy and mild periventricular hyperintensities.
There was a question of mild communicating hydrocephalus.
She was placed on 15 days of IV ganciclovir for meningoencephalitis with positive EBV PCR in CSF.
A repeat head MRI without gadolinium showed 3 hyperintense FLAIR lesions in the left caudate, right parietal periventricular region, and left frontal region near the surface of the brain.
It showed focal increased uptake in known right parietal (SUVmax 5.0) and left basal ganglia lesions (SUVmax 6.8), and there was no FDG avid disease outside the brain.
She has hypertension and hypercholesterolemia, but no COPD.
Reports: [**2199-9-14**] CXR: There is new development of bilateral vascular engorgement, upper zone redistribution of vasculature, interstitial extensive opacities and bilateral perihilar alveolar opacities continuing toward the lung bases, findings that are representing interstitial-alveolar pulmonary edema, at least moderate in severity.
[**2199-9-15**] CXR:  In comparison with study of [**9-14**], there has been a substantial decrease in the pulmonary vascular congestion.
Bibasilar opacification persists, consistent with pleural effusion and compressive atelectasis.
Micro: [**2199-9-14**] Urine culture: no growht to date [**2199-9-14**] Blood culture x 4: no growth to date [**2199-9-15**] Blood culture: no growth to date   Brief Hospital Course: This is a 39 year old female with ESRD s/p panc/kidney transplant, recently diagnosed with CNS lymphoma.
She continued to get IV fluids to help clear MTX until [**2199-9-14**] when she developed flash pulmonary edema.
She was given Lasix 40mg IV BID and her oxygen requirement which was initially 4L.
# Hypertension: In the [**Hospital Unit Name 153**] her atenolol was switched to carvedilol and her amlodopine was continued.
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime)  as needed for sleep/anxiety.
Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day as needed for swelling.
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia.
Central Nervous System Lymphoma 2.
Diabetes Type I s/p kidney and pancreas transplant .
Secondary: 1) Hypertension   Discharge Condition: Stable   Discharge Instructions: You were admitted the hospital for chemotherapy.
You developed subconjunctival hemorrhages in your eye likely secondary to temporarily high blood pressure.
You also developed fluid in your lungs as a complication of high blood pressure.
Please seek medical care if you develop nausea, vomiting, fevers/chills, shortness of breath, dizziness, fainting, chest pain, eye pain or vision changes.
